Assessing the potential impact of non-proprietary drug copies on quality of medicine and treatment in patients with relapsing multiple sclerosis: the experience with fingolimod. [electronic resource]
- Drug design, development and therapy 2014
- 859-67 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't